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In Huntington’s disease (HD), while the ubiquitously expressed mutant Huntingtin
(mtHTT) protein primarily compromises striatal and cortical neurons, glia also undergo
disease-contributing alterations. Existing HD models using human induced pluripotent
stem cells (iPSCs) have not extensively characterized the role of mtHTT in patient-
derived astrocytes. Here physiologically mature astrocytes are generated from HD
patient iPSCs. These human astrocytes exhibit hallmark HD phenotypes that occur
in mouse models, including impaired inward rectifying K+ currents, lengthened
spontaneous Ca2+ waves and reduced cell membrane capacitance. HD astrocytes in
co-culture provided reduced support for the maturation of iPSC-derived neurons. In
addition, neurons exposed to chronic glutamate stimulation are not protected by HD
astrocytes. This iPSC-based HD model demonstrates the critical effects of mtHTT on
human astrocytes, which not only broadens the understanding of disease susceptibility
beyond cortical and striatal neurons but also increases potential drug targets.
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INTRODUCTION
Huntington’s disease (HD) is a fatal neurodegenerative disease that presents with involuntary
motor control as well as cognitive and psychiatric disturbances. HD is directly linked to over 40
CAG trinucleotide repeats in the first exon of the Huntingtin gene (Andrew et al., 1993). The
number of CAG repeats has a positive correlation between the age-of-onset of symptoms and
severity of the disease. When translated, the CAG repeat produces an expanded polyglutamine
repeat (polyQ) in the mutant Huntingtin (mtHTT) protein. Though mtHTT is ubiquitously
expressed, it primarily leads to dysfunction and progressive death of medium spiny neurons
(MSNs) in the striatum, and subsequently cortical projection neurons (Macdonald and Halliday,
2002; Thu et al., 2010; Ross and Tabrizi, 2011). It is still unclear whether this expansion causes a
gain of toxic functions, loss of physiological functions of the protein, or both (see Jimenez-Sanchez
et al., 2017 for review). Despite knowing for over two decades that expanded HTT underlies HD,
there is still no successful treatment or comprehensive understanding of the selective neuronal loss.
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While neuronal degeneration is central to HD, glial cells also
display disease-related phenotypes in HD patients and rodent
models (Khakh et al., 2017). Specifically, dysfunctional astrocytes
have been shown to play critical roles in the neuronal decline
(Khakh and Sofroniew, 2014; Tong et al., 2014; Jiang et al., 2016).
HD rodent astrocytes demonstrate impaired glutamate uptake,
which increases activation of neuronal NMDA receptors leading
to neurotoxicity (Milnerwood et al., 2010). In addition, impaired
K+ buffering via reduced inward rectifying K+ currents causes
rapid changes to the excitability of neurons in response to rates of
action potential propagation (Tong et al., 2014).
Induced pluripotent stem cells (iPSCs) (Takahashi
and Yamanaka, 2006) can be differentiated to provide a
disease-relevant source of human neural cell types. Human
iPSC-derived HD neurons have been co-cultured with healthy
rodent-derived glia, which improve the electrophysiological
function and survival of iPSC-derived neurons (Tang et al.,
2013). However, the rodent origin prohibits the study of
human HD glial phenotypes. Patient-derived iPSCs are a
promising cell source to derive mature astrocytes to model
their dysfunction in neurodegenerative diseases (Khakh
et al., 2017). Co-culture with neurons may enhance the
astrocyte maturation process; however, pure astrocytes
would be ideal to distinguish the specific role of astrocytes
versus neurons in HD. Furthermore, deriving terminally
differentiated astrocytes without passaging would reduce the
risk of generating reactive astrocytes that could confound
disease-specific phenotypes.
In a chimeric mouse model, human HD iPSC-derived
glia surrounding non-diseased murine MSNs led to neuronal
hyperexcitability and reduced motor performance (Benraiss
et al., 2016). In addition, HD patient iPSC-derived astrocytes
display autophagocytic vacuoles (Juopperi et al., 2012)
and increased evoked inflammatory responses (Hsiao
et al., 2014). However, these studies did not assess the
functional maturity of the iPSC-derived astrocytes. And,
notably, studies to date have yet to investigate whether
patient-derived HD astrocytes directly affect human
neuronal function.
Here, we present a novel protocol to differentiate patient iPSCs
into a pure population of human HD astrocytes. The astrocytes
were functionally mature, displaying electrophysiological profiles
not typically observed in less mature or stress-activated
astrocytes. This included inward rectifying K+ currents that were
altered in the HD astrocytes, which corroborates previous results
in HD (Tong et al., 2014). At early stages in co-culture, HD
astrocytes, compared to control astrocytes, provided less support
for the maturation of HD and control neurons. Furthermore,
the HD astrocytes, compared to controls, did not protect HD
or control neurons from toxicity following chronic glutamate
exposure. Our data from iPSC-based HD astrocytes recapitulates
findings from patient post-mortem samples and HD mouse
astrocytes (Khakh et al., 2017), validating this novel use of
patient iPSCs to derive pure functional astrocytes. These human
astrocytes provide an ideal model to investigate mechanisms of
astrocyte–neuron interactions in HD as well as to identify novel
therapeutic targets.
MATERIALS AND METHODS
iPSC Lines
The iPSC lines used in this study were purchased from the
Induced Pluripotent Stem Cell Core at Cedars-Sinai (Los Angeles,
CA, United States). All lines were reprogramed from fibroblast
cells. Control lines included CS83iCTR33n (female, age 21,
clinically normal); CS00iCTR21n (male, age 6, clinically normal);
and CS25iCTR18n (male, 76, clinically normal, brother of
affected sibling). HD lines include CS09iHD109n (female, age
unknown, clinically affected with 109 and 119 CAG repeats)
and CS77iHD77n (male, age unknown, clinically affected with
77 CAG repeats). These lines have tested as karyotypically
normal and the CAG repeat lengths measured using automated
genotyping on an ABI 3100 (HD iPSC Consortium, 2012).
Astrocyte Differentiation
All five lines were first differentiated into neural progenitor
cells (NPCs) by growing the cells in suspension in media
supplemented with epidermal growth factor and fibroblast
growth factor (Ebert et al., 2013). The cultures were
mechanically propagated as EZ spheres in growth media [70:30
DMEM:F12 (Life Technologies), 2% B27 without vitamin A (Life
Technologies), 1% anti-biotic/anti-mycotic (Life Technologies),
100 ng/ml EGF (Peprotech) and FGF (Peprotech)], as described
by Ebert et al. (2009). After a minimum of 10 mechanical
passages in weekly intervals, the lines were differentiated to
astrocytes using the protocol described below.
Stage 1: At between passages 10 and 30, EZ spheres
were dissociated to a single cell suspension using TrypLE
(Thermo Fisher Scientific). The ratio of live:dead cells was
determined using a hemacytometer by Trypan Blue exclusion.
The dissociated NPCs were then plated on poly-L-lysine and
laminin-coated glass coverslips at a density of 25,000 live cells per
13 mm coverslip in 24-well plates. The cells were seeded in 80 µl
of base medium [DMEM:F12 1:1, 2% B27 (Life Technologies)
and 1% antibiotic/antimycotic] and cultured overnight in order
increase adherence of the cells to the coverslip. The coverslips
were then flooded with the Stage 1 astrocyte differentiation
medium [DMEM:F12 1:1, 2% B27, 1% antibiotic/antimycotic
and 1 µM Arabinosylcytosine (Ara-C; Sigma-Aldrich)]. NPCs
were cultured for a week in this medium with half medium
changes every 3 days.
Stage 2: To remove the Ara-C after 1 week, the adherent
cells were washed twice with base medium before being cultured
in the Stage 2 astrocyte medium [DMEM:F12 1:1, 2% B27, 1%
antibiotic/antimycotic and 10 ng/ml Lif-1 (Millipore Sigma)] for
1 week, with medium changes every 3 days.
Stage 3: Following 1 week in Stage 2 medium, the cells were
dissociated using TrypLE for 5 min to generate a multi-cell
suspension lifted from the coverslip. The cells were then washed
in base medium and seeded in T25 Nunc tissue culture flasks.
The cells were then fed Stage 3 astrocyte differentiation medium
[DMEM:F12 1:1, 8% heat inactivated fetal bovine serum (hiFBS),
1% antibiotic/antimyotic and 10 ng/ml Lif-1], which was changed
every 5 days. These cells were considered the “Stage 3” astrocytes
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and were used experimentally. Confluent cells were passaged at a
ratio of 1:3, typically every 2 weeks. These Stage 3 cells could be
frozen for later experimentation or re-plated onto glass coverslips
for immediate study (see below).
Stage 4: The final stage of astrocyte differentiation generated
the most functionally mature astrocytes. The Stage 3 cells
were dissociated using TrypLE and re-seeded on 13 mm glass
coverslips at a density of 50,000 cells per coverslip (or higher,
dependent upon the particular iPSC line). Cells were left
overnight in Stage 3 medium before it was changed to Stage 4
medium [DMEM:F12 1:1, 8% hiFBS, 1% antibiotic/antimyotic,
10 ng/ml Lif-1, 20 ng/ml ciliary neurotrophic factor (CNTF;
R&D), 20 ng/ml bone morphogenic protein -4 (BMP-4; R&D)
and 5 µM N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenyl-
glycine-1,1-dimethylethyl ester (DAPT; R&D)]. If necessary,
the cells were cultured longer in Stage 3 medium to achieve
confluence prior to the final differentiation in Stage 4 medium,
which was important for their survival. After 1 week in this
Stage 4 medium, these cells were considered the mature “Stage 4”
astrocytes, which were used for the experiments described below.
Neural Differentiation
iPSC cultures were grown to 70% confluence on Matrigel-coated
plates in mTESR medium (Stemcell Technologies). Using a
protocol adapted from a previously published ventral forebrain
protocol (Telezhkin et al., 2016), iPSCs were switched to SLI
medium [Advanced DMEM/F12 (Invitrogen) 1:1 Neurobasal A
(Invitrogen), 1% Glutamax (Life Technologies), 2% B27 without
vitamin A, 10 µM SB-431542 (Tocris), 1.0 µM LDN-193189
(Stemgent), 1.5 µM IWR1 (Tocris)], and the medium was
changed daily. On day 4, 10 µM Y-27632 (Abcam) was added
to the cultures 1 h prior to passaging. The cultures were washed
with 1X PBS (Corning), treated with accutase (Millipore) for
5 min, agitated to loosen, and centrifuged at 150 x g for 3 min.
After the supernatant was aspirated, the cells were resuspended
in SLI medium containing 10 µM Y-27632 and seeded on a
Matrigel-coated plate at a 1:2 density. The cultures were fed
daily with SLI medium. On day 8, the cells were passaged
1:2 as described above and seeded onto Matrigel-coated plates
in LIA medium [Advanced DMEM/F12 1:1 Neurobasal A, 1%
Glutamax, 2% B27 without vitamin A, 200 nM LDN-193189,
1.5 µM IWR1, 20 ng/mL Activin A (R&D)] containing 10 µM
Y-27632. The cultures were then fed daily with LIA medium.
On day 16, the neural progenitor cells (NPCs) were passaged,
as described above, and were re-suspended in plating medium
(Advanced DMEM/F12 1:1 Neurobasal A, 1% Glutamax, 2% B27
without vitamin A) at a concentration of 1 x; 106 cells/mL. The
neuronal progenitors were then seeded at a density of 25,000 cells
per coverslip on either matrigel-coated glass coverslips or glass
coverslips previously seeded with astrocytes matured to Stage
4, as described below. Excess cells (∼day 16 of differentiation)
were cryopreserved in CryoStor freezing medium for use in
later experiments.
Astrocyte Co-culture
Stage 3 astrocytes were plated and differentiated for 1 week in
Stage 4 medium before seeding the NPCs on top. Dissociated
NPCs were plated at a density of 25,000 per coverslip on top
of confluent Stage 4 astrocytes. From this point, only neuronal
differentiation/maturation media were used, with no further
supplements for the astrocytes.
The neuronal/astrocyte co-cultures were maintained using
the SynaptoJuice Protocol (Kemp et al., 2016). During the
first week, the cells were differentiated in SynaptoJuice-
A medium [Advanced DMEM/F12 1:1 Neurobasal A, 1%
Glutamax, 1% antibiotic/antimyotic, 2% B27 without vitamin
A, 2 µM PD0332991 (Tocris), 10 µM DAPT, 10 ng/mL BDNF
(Miltenyi), 500 nM LM22A4 (Tocris), 10 µM forskolin (Tocris),
3 µM CHIR99021 (Tocris), 300 µM GABA (Tocris), 1.8 mM
CaCl2 (Sigma), 200 µM ascorbic acid (Sigma)]. SynpatoJuice-
A was changed on day 2 and day 5 after plating. On day 7
post-plating, SynaptoJuice-A was replaced with SynaptoJuice-
B differentiation/maturation medium (Advanced DMEM/F12
1:1, Neurobasal A, 2% Glutamax, 1% antibiotic/antimyotic,
2% B27, 2 µM PD0332991, 10 ng/mL BDNF, 500 nM
LM22A4, 3 µM CHIR99021, 1.8 mM CaCl2, 200 µM ascorbic
acid). SynaptoJuice-B was changed every 3 days for up to
day 24 days post-plating, at which time the cultures were
fixed for immunocytochemistry.
Immunocytochemistry
Immunocytochemistry was performed on poly-ornithine coated
13 mm glass coverslips in 24 well tissue culture plates. Cells were
fixed with 4% paraformaldehyde in phosphate buffered saline
(PBS) for 10 min at room temperature and then rinsed 3 times for
3 min with PBS. Cells were blocked in 10% bovine serum albumin
and 1% TritonX-100 for 1 h at room temperature and then
incubated overnight at 4oC with antibodies diluted in blocking
solution. The following antibodies were used: GFAP (rat, Agilent
Technologies Cat# Z0334, RRID:AB_10013382; dilution 1:2500),
S100β (mouse, Sigma-Aldrich Cat# S2532, RRID:AB_477499;
1:1000), β3-tubulin/TuJ1 (rabbit, Sigma-Aldrich Cat# T2200,
RRID:AB_262133; 1:1000), and gamma aminobutyric acid
(GABA; rabbit, Sigma-Aldrich Cat# A2052, RRID:AB_477652;
1:500). Cells were then washed 3 times and incubated for 1 h
at room temperature in green and red fluorescent-conjugated
secondary antibodies (Alexa Fluor 448 and Alexa Fluor 594,
respectively), diluted at 1:500 in blocking solution with 1%
normalized serum from the host species of the secondary
antibodies. Cells were then washed 3 times, and incubated with
the fluorescent nuclear stain, DAPI, followed by two washes.
The coverslip was then mounted on a glass microscope slide
using fluoromount-G.
Whole-Cell Patch Clamp
Whole-cell patch clamp was performed on Stage 3 and Stage
4 astrocyte cultures. Glass micropipettes were pulled using a
Sutter Instruments P-1000 from thin wall borosilicate glass
capillaries (World precision instruments) with a tip resistance of
between 4 and 6 M. Cells were visualized using a Leica DM-
LED microscope. Voltage and current clamp recordings were
performed using a Molecular Devices Multiclamp 700B amplifier,
Digidata 1300 converter, and PClamp 10 acquisition software
(Molecular Devices). Astrocytes with an access resistance above
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35 M were excluded. Cells were bathed in an extracellular
solution (ECS) containing (in mM): 135 NaCl, 5 KCl, 5 HEPES,
10 Glucose, 1.2 MgCl2, and 1.25 CaCl2. The internal solution
comprised (in mM): 10 NaCl, 117 KCl, 11 HEPES, 2 Na.ATP, 2
MgCl2 and 1 CaCl2. The cell’s capacitance and access resistance
was measured using a 10 mV test pulse from a holding voltage of
−70 mV. Channel blockers were perfused with a rapid solution
changer (BioLogic Science Instruments).
A voltage-step protocol was used both with and without
online leak subtraction to record voltage-gated Na+ (NaV ),
voltage-gated K+ (KV ), inward rectifying K+ (Kir) and tandem
pore potassium (K2P) currents. Starting from a holding voltage
of −70 mV, a 100 ms voltage-step was applied, starting at
−120 mV and increasing in 10 mV increments to +40 mV.
NaV currents were observed as rapidly activating and inactivating
inward currents immediately following the start of voltage-steps
above approximately −40 mV, and were sensitive to 0.5 µM
Tetrodotoxin (TTX; Tocris). KV currents were observed as more
slowly activating outward currents at voltages more positive than
−20 mV which did not completely inactivate during the 100 ms
step and were sensitive to 10 mM Tetraethylammonium chloride
(TEA; Tocris). Kir currents were observed as a persistent inward
current at voltage steps below approximately −80 mV and were
sensitive to 10 µM Nortriptyline- and Ba2+-containing ECS [in
mM: 95 NaCl, 5 KCl, 5 HEPES, 10 Glucose, 1.2 MgCl2, 27
BaCl2 (Sigma-Alrich), 0.01 Nortriptyline hydrochloride (Sigma-
Aldrich)]. K2P currents were only observable in the absence of
leak subtraction, and were a non-linear, Goldman-Hodgkin-Katz
rectifying current which was insensitive to 10 µM TEA, but
sensitive to 10 µM Quinidine (Sigma-Aldrich).
Resting membrane potential (RMP) was assessed in current
clamp by averaging from continuous voltage recordings with
a 0 pA holding current. Input resistance was measured using
200 ms current-steps, starting at +10 pA and increasing in
10 pA increments to +180 pA. The input resistance was then
calculated using Ohms law.
Microelectrode Array
Astrocytes at Stage 3 were thawed into flasks and grown
for a week before passage. HD (CS09iHD109n1) and control
(CTR; CS83iCTR33n2) astrocytes were then seeded onto 48-
well transparent microelectrode array (MEA) plates (Axion
Biosystems) at between 25 and 200 thousand cells per well.
Astrocytes were allowed up to 2 days in Stage 3 media after
seeding before switching to Stage 4 media for maturation. After
1 week in maturation, control and HD neural progenitors (∼day
16 of differentiation) were seeded on top of the astrocytes at
between 50 and 400 thousand cells per well and the co-culture
experiment was considered at Day 0. Daily recordings of activity
were measured using the Maestro MEA platform and recording
software (Axion Biosystems) for 5 min durations. Wave form
events were identified using adaptive spike threshold crossing
with a standard deviation of noise set at 5.5, and then further
validated and sorted to individual neurons using Oﬄine Sorter
(Plexon). A minimum of 1 spike per min was used to include
neuronal waveforms for analysis, and PCA analysis of each unit
cluster was used to exclude noise artifacts. Data was compiled
in excel and statistics run using GraphPad Prism 7.04 and
SigmaPlot software.
ELISA
A standard dilution curve (500 to 7.8 µg/mL) was generated
by serial dilution of human thrombospondin-1, with a negative
control of assay diluent. Each astrocyte-conditioned medium
sample was assayed at full and half concentration, diluted
in base medium, and additionally the base medium was
sampled as a negative control. Thrombospondin-1 was
quantified in astrocyte-conditioned medium using a human
thrombospondin-1 Quantikine ELISA Kit (R&D Systems),
following the manufacturer’s instructions. The plate was
read at an excitation wavelength of 450 nm, simultaneously
correcting for a 570 nm background signal. The generated
standard curve was then used to calculate the concentration of
thrombospondin-1 in astrocyte conditioned medium.
Cell Counts
Fluorescent imaging of astrocyte cultures was performed on
a Leica microscope, model DM6000 B. Images were taken
from DAPI (400 nm), GFP (470 nm), Texas red (560 nm),
and Y5 (620 nm) channels using 10x; and 20x; air objectives.
Images were acquired using Leica Application Suite X (Leica
Microsystems). Several random and representative images were
taken per coverslip and manually counted using ImageJ. Cell
bodies, or appropriate cell regions staining positive for cell
markers, were counted and expressed as a ratio of the total
DAPI-positive cell nuclei counts.
Cells in the neuronal cultures were noted to have much
smaller nuclei compared to those in the astrocyte cultures.
Nuclei were measured after 16 days of glial differentiation
followed by 6 days in neuronal media with or without co-culture.
Nuclei size was measured with the Zeiss stereological software
nucleator feature using 8 rays, 1 marker per interval. Neuronal
cultures and neuronal-astrocyte co-cultures were quantified (at
6 days post-plating) with Zeiss stereological investigator software
using a 20x air objective. Cells in the co-cultures were divided
into two groups based upon their nuclei size as a means of
distinguishing whether they originated from the neuronal or
astrocyte differentiation protocols.
Ca2+ Imaging
Six days post-co-culture plating and maintenance in neuronal
media, HD (CS09iHD109n1) and control (CS83iCTR33n2) cells
were incubated with 5 µM Fluo-3-AM (Fluo-3) for 30 min in
their culture medium at 37◦C. Excess Fluo-3 was then washed
out and replaced with fresh media. Fluo-3 was excited at 490 nm
and emission was recorded at 530 nm using a Leica microscope
model DM6000 B equipped with a DFC360FX CCD camera.
Excitation exposure was between 25 to 35 ms with a gain
between 5 and 8x, depending upon region of interest with an
acquisition rate of 15.5 Hz. Fluorescence intensity was measured
over time in several regions of interest on both astrocytes
and neurons using ImageJ software. Off-line subtraction was
performed by measuring fluorescence in a region of interest
which did not contain cells or cell extensions. Astrocyte- or
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neuron-dependent events were discriminated by correlating the
cell morphology (using transmitted light) with duration of Ca2+
response, and further confirmed by the addition of TTX to block
Nav-dependent action potentials in neurons.
Glutamate Response and LDH Activity
For each of three experiments, four assays were performed,
beginning on day 1 after transition to SynaptoJuice B, and
each assay was separated by 4–5 days over the 16-day culture
duration. Spontaneous MEA recordings were taken up to 1 h
before addition of glutamate. Glutamate (100 µM) was then
added to each well of the 48-well plate and the neural activity
was immediately recorded (note: Advanced DMEM/F12 contains
0.05 mM glutamate). The plate was then incubated for 12 h
at 37◦C, followed by a recording of activity of the neurons
under chronic glutamate exposure. Media was sampled from
every well and pooled by cell group (control astrocytes alone,
HD astrocytes alone, control astrocytes with control neurons or
HD neurons, and HD astrocytes with control neurons or HD
neurons). The concentration of lactate dehydrogenase (LDH) was
then measured using a Pierce LDH cytotoxicity assay kit (Thermo
Fisher Scientific) per the manufacturer’s protocol.
Statistics
Chi Squared tests were performed on data with a categorical or
binomial dependent variable. T-tests were performed on data
with a continuous dependent variable, following inspection to
be sure that the data were normally distributed around each
hypothesized mean. Depending on the distribution of the data
set, either a parametric or non-parametric analysis of variance
was performed on data sets with more than two groups. Nuclei
sizes were compared with a one-way ANOVA followed by a
Bonferroni post-test. Outliers were excluded from MEA data of
spontaneous activity if they exceeded ±2 standard deviations
from the mean of three experiments. Post hoc tests were then
chosen according to the data sets and are stated. Unless stated
otherwise, continuous data are reported as mean ± standard
error of the mean.
RESULTS
Human iPSCs Provide a Pure Population
of Astrocytes That Produce Hallmark
Proteins
To examine the influence of HD on astrocytes, astrocytes
were differentiated from previously described control
(18, 21, or 33 CAG repeats) and HD patient (77 or 109
CAG repeats) iPSC lines (HD iPSC Consortium, 2012).
The differentiation protocol consisted of four separate,
week-long “stages” that were specifically chosen to rapidly
generate mature astrocytes (Figure 1A). In Stage 1, iPSC-
derived NPCs were treated with 1 µM Ara-C, which
inhibits cell division. This was used as neural progenitors
require cell division for neurogenesis (Nelson et al.,
2008), thereby low doses of Ara-C were used to block
neuronal generation. Compared to untreated NPCs, cultures
treated with Ara-C contained little to no TuJ-positive neurons
(Supplementary Figure 1). In Stage 2, Ara-C was replaced by
Lif-1 to induce astrogliogenesis (Wright et al., 2003). In Stage 3,
cells were switched into a Lif-1 and high fetal bovine serum
(FBS)-containing medium to elicit astrocyte proliferation.
Finally, in Stage 4, cells were switched into medium containing
further astrogliogenic factors (BMP-4 and CNTF), as well as a
G-secretase inhibitor (DAPT) to encourage synchronous terminal
differentiation and maturation (Telezhkin et al., 2016).
Immunocytochemistry assessment of Stages 3 and 4 astrocytes,
from both control and HD iPSC lines, showed a typical
large filamentous astrocyte morphology as well as expression
of the known astrocyte markers glial fibrillary acidic protein
(GFAP) and S100β (Figure 1B). The relative expression of these
two proteins can indicate the degree of astrocyte maturation,
with GFAP expression present in neural precursors and S100β
expression present in more mature astrocytes (Raponi et al.,
2007). Quantifying the percent of total cells expressing astrocyte
markers showed that Stages 3 and 4 cultures had a high percentage
of both GFAP+ and/or S100β+ cells (Figure 1C). During the
transition from Stage 3 to Stage 4, both control and HD lines had a
significant loss of GFAP-positive/ S100β-negative cells (p< 0.001;
Figure 1C). HD and control cells both expressed markers of
mature astrocytes in similar proportions at Stages 3 and 4.
The secretion of neurogenic and synaptogenic factors by
astrocytes is critical to their function, and pertinent for co-culture
studies using astrocytes to enhance neuronal differentiation.
Thombospondin-1 (TSP1) is one such synaptogenic factor
generated by astrocytes in the developing central nervous system
(Chung et al., 2015). To determine the relative functionality
of iPSC-derived astrocytes, a TSP1 ELISA was performed on
medium conditioned by astrocytes for 24 h. Results revealed
a significant increase in TSP1 secretion from Stage 3 to
Stage 4 (p < 0.001; Figure 1D), which was not due to cell
number differences as subsequent cell fixation and counts
confirmed similar cell numbers between Stages 3 and 4 cultures
(data not shown). The increased TSP1 secretion from Stage 4
astrocytes supports that the final differentiation step generates
functionally mature astrocytes. Similar GFAP and S100β protein
production, HD and control astrocytes in Stages 3 and 4 have no
difference in TSP1 levels.
Human iPSCs Provide a Range of
Functionally Mature Astrocytes
In addition to protein expression (Raponi et al., 2007), glial fate
can be validated by specific electrophysiological characteristics.
Functional traits are cell-specific and demonstrate quantifiable
ontogenies during development through to maturity (Shelton
and McCarthy, 1999; Zhou et al., 2006). Specifically, immature
astrocytes display significant Kv currents and even small Nav
currents, reminiscent of very immature neurons (Zhou et al.,
2006). As astrocytes mature, they express progressively larger Kir
and K2P currents (Higashi et al., 2001; Zhou et al., 2006).
To establish the functional maturity of the Stages 3
and 4 astrocytes, we employed whole-cell patch clamp
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FIGURE 1 | Huntington’s disease and control iPSCs are equally capable of generating mature astrocytes. (A) Schematic of astrocyte differentiation from
iPSC-derived neurospheres. (B) Immunocytochemistry of Stages 3 and 4 astrocytes stained for GFAP and S100β. (C) Stage 3 (left) and Stage 4 (right) display
astrocyte markers GFAP and/or S100β in equal percentages between HD and controls. (n = at least three independent experiments per line and more than 1,900
DAPI-positive cells). (D) Stage 4 astrocytes derived from either HD or control iPSCs release more TSP1 than Stage 3 astrocytes in all lines tested, indicative of
increased maturity (∗∗∗p < 0.001; n = 3–5 independent differentiations).
electrophysiology to measure ionic currents that are fundamental
to astrocyte function. Four electrophysiological types of
astrocytes were identified in our cultures and were termed
Types A through D. Type A (Figure 2A, left) astrocytes were
characterized as having both Kv and Nav currents. Highly
immature astrocytes and astrocyte precursors generate very small
voltage-gated K+ and, if present, voltage-gated Na+ currents
(Zhong et al., 2016). While this suggests immature neurons,
we have shown that these cells are almost entirely GFAP+
and/or S100β+ (Figure 1B) and have little to no observed
TuJ1 staining (Supplementary Figure 1). Collectively, these
phenotypes suggest that Type A cells are precursor astrocytes
rather than neurogenic. Type B astrocytes expressed only Kv
currents (Figure 2A, right), also indicative of an immature
astrocyte progenitor. Pharmacological analysis of the ion
channels in Type A and B astrocytes demonstrated the presence
of Tetraethylammonium chloride (TEA)-sensitive Kv currents
(Figure 2B), as would be expected for a progenitor (Lai et al.,
2010). When examining the K+ current densities between
the immature (Type A and B) control and HD astrocytes, no
differences were observed (CTR: 20.93 ± 0.92 pA/pF, HD:
22.12 ± 0.98 pA/pF, n = 23 CTR, 24 HD; Figure 2C). To further
investigate any HD-related differences in this population of
immature astrocytes, we next examined their passive membrane
properties. The resting membrane potential (RMP) in glia is
important for the control of cell excitability, and contributes to
the buffering of extracellular K+ and uptake of neurotransmitters
(McKhann et al., 1997). The RMP was lower in HD compared to
control (CTR: −51.24 ± 1.0 mV, HD: −57.30 ± 0.90 mV, n = 56
CTR, 24 HD; p < 0.0001; Figure 2D). Input resistance, a crude
measure of the concentration of ion channels present on the cell
surface, was higher in the HD astrocytes (CTR: 1036 ± 26.18
M, HD: 1188 ± 27.49 M, n = 56 CTR, 30 HD; p = 0.0001;
Figure 2E). And cell capacitance, a precise measure of the cell
surface area, was smaller in HD lines compared to controls
(CTR: 27.57± 0.71 pF, HD: 23.40± 0.90 pF, n = 54 CTR, 30 HD;
p = 0.0007; Figure 2F).
Over the course of astrocyte development and maturation,
Kir channels are expressed (Seifert et al., 2009), with Kir-
positive astrocytes present at higher concentrations in the
developing brain. Corroborating this in vivo phenotype, another
electrophysiological phenotype present in the Stage 3/4 cultures,
termed Type C astrocytes, expressed Kir currents (Figure 3A).
Furthermore, pharmacological analysis showed that Type C
astrocytes expressed TEA-resistant, nortriptyline-sensitive Kir4.1
channels (Figure 3B). While Type A/B astrocytes had similar
KV current densities between HD and control lines, Type C
HD astrocytes expressed smaller peak Kir currents compared to
controls (CTR: 4.25± 0.22 pA/pF, HD: 3.01± 0.21 pA/pF, n = 13
CTR, 15 HD; p < 0.0001; Figure 3C). HD Type C astrocytes also
differed in passive membrane properties, including depolarized
RMP values (CTR: −74.93 ± 0.70 mV, HD: −68.82 ± 0.93 mV,
n = 14 CTR, 14 HD; p < 0.0001; Figure 3D), greater input
resistances for HD astrocytes (CTR: 570.20 ± 36.27 M, HD:
765.7 ± 25.2 M, n = 17 CTR, 14 HD; p = 0.0001; Figure 3E)
and less capacitance (CTR: 34.59 ± 1.34 pF, HD: 28.36 ± 1.14
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FIGURE 2 | Stages 3 and 4 HD iPSC-derived astrocytes display reduced capacitance as committed but immature Type A/B astrocytes. (A) iPSC-derived astrocytes
mature from astrocyte progenitors expressing voltage-gated Na+ and K+ currents (Type A, left), to immature astrocytes expressing some voltage-gated Na+ but
mostly voltage-gated K+ currents (Type B, right). (B) Example current-voltage (IV) curve of voltage-gated K+ current density from HD, control and control + TEA in
Type A/B astrocytes. (C) Immature astrocytes display no differences in the peak voltage-gated K+ current density between HD and control. (D) Type A/B HD
astrocytes have more hyperpolarized resting membrane potentials compared to control and (E) higher input resistance. (F) Immature HD astrocytes show smaller
capacitances compared to controls. Each cell is represented as a single point, and therefore N is represented on each graph. These cells were analyzed from more
than three separate experiments (∗∗∗p < 0.005 and ∗∗∗∗p < 0.001).
pF, n = 17 CTR, 14 HD; p = 0.0014; Figure 3F) compared
to control lines.
Astrocytes within the adult brain predominantly display large
K2P currents (Seifert et al., 2009), which were identified in
the final electrophysiological phenotype present in the Stage
3/4 cultures, termed Type D astrocytes (Figure 3G). iPSC-
derived Type D astrocytes expressed quinidine-sensitive K2P
channels that indicate a mature astrocytic fate (Figure 3H).
These astrocytes did not demonstrate any difference in the
peak K+ current density between HD and control lines (CTR:
7.06 ± 0.38 pA/pF, HD: 7.01 ± 0.35 pA/pF, n = 12 CTR, 13
HD; Figure 3I). Similarly, passive membrane properties such
as RMP (CTR: −77.07 ± 0.73 mV, HD: −76.29 ± 0.83 mV,
n = 15 CTR, 13 HD; Figure 3J) and input resistance
(CTR: 372.50 ± 20.78 M, HD: 361.20 ± 23.50 M,
n = 12 CTR, 13 HD; Figure 3K) were not different between
HD and control lines. However, HD Type D astrocytes
had lower capacitance values compared to controls (CTR:
41.13 ± 1.44 pF, HD: 32.81 ± 1.25 pF, n = 15 CTR, 13 HD;
p = 0.0002; Figure 3L).
Collectively, these results demonstrate that this new protocol
can differentiate both control and HD iPSC lines into a
population of primarily pure astrocytes, and that these astrocytes
vary in maturity levels that can be characterized by different
electrophysiological properties. Astrocytes “Type A-D” are
indicative of increasing maturity levels and, indeed, a detailed
analysis of passive properties showed differences between
the astrocyte Types driven by maturation (Supplementary
Figure 2). While in stage 3 media, only Type A (34.4 ± 8.9%
total cells) and Type B (65.6 ± 8.9%) astrocytes were
observed (Supplementary Figure 2A). However, when cultured
in the final, stage 4 media which promotes functional
maturation of the astrocytes, a significant drop in Type A
astrocytes was observed (3.2 ± 3.1% total cells), while the
proportion of mature Type C and D astrocytes increased
(Type B: 39.4 ± 2.73%, Type C: 31.2 ± 3.57%; Type D:
26.0 ± 1.92% total cells; Supplementary Figure 2A). Type
C and D astrocytes demonstrated hyperpolarized RMP (Type
A&B: −53.10 ± 2.25 mV, Type C: −72.41 ± 1.53 mV,
Type D: −77.10 ± 0.61 mV, n = 1 mean value per line,
5 lines; p < 0.0001; Supplementary Figure 2B), decreased
input resistance (Type A&B: 1090 ± 49.76 M, Type
C: 651.40 ± 48.94 M, Type D: 369.50 ± 9.51 M;
p < 0.0001; Supplementary Figure 2C) and larger cell
capacitance (Type A&B: 25.65± 1.219 pF, Type C: 32.12± 1.674
pF, Type D: 38.99 ± 3.08 pF; Type D vs. Type A&B
p = 0.0028; Supplementary Figure 2D) when compared to
the immature Type A/B astrocytes. Additionally, the most
mature Type D astrocyte had a lower input resistance compared
to Type C astrocytes (p = 0.0011). This maturation in
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FIGURE 3 | Huntington’s disease iPSC-derived Kir channel-expressing (Type C) astrocytes display different current densities, resting membrane potential, input
resistance and capacitance. (A) Type C astrocytes express Kir currents in Stages 3 and 4 cultures. (B) Example IV curve from Type C HD, control and control +
nortriptyline astrocytes. (C) Type C HD astrocytes display significantly less peak Kir current density as compared to controls. (D) Type C HD astrocytes have
depolarized resting membrane potentials and (E) an increased input resistance compared to controls. (F) Type C HD astrocytes have decreased capacitance
compared to controls. (G) Mature Type D astrocytes express K2P currents in Stages 3 and 4 cultures. (H) Example IV curve of K+ current density from Type D HD,
control and control + TEA and quinidine astrocytes. (I) Peak K2P current density, (J) resting membrane potential, and (K) input resistance are similar between HD
and control Type D astrocytes. (L) Type D astrocytes have smaller capacitances than control. Each cell is represented as a single point, and therefore N is
represented on each graph. These cells all came from more than three separate experiments (∗∗p < 0.01; ∗∗∗p < 0.005; and ∗∗∗∗p < 0.0001).
electrophysiological properties was conserved across HD and
control astrocytes.
HD Astrocytes Are Less Supportive of
Neuronal Spontaneous
Electrophysiological Activity Than
Control Astrocytes as Evidenced by
Ca2+ Imaging Experiments
Because the HD109 line demonstrated more pathotypes than
the HD77 line, this more severe HD patient line was used
in subsequent experiments and compared to the CTR33 line.
As astrocytes promote neuronal development (Pfrieger and
Barres, 1997; Pfrieger, 2010), the contribution of HD astrocytes
to neuronal physiology was assessed by co-culturing Stage 4
HD astrocytes with iPSC-derived striatal neurons (Telezhkin
et al., 2016). To provide functional references, HD and control
astrocytes and neurons were also analyzed alone in mono-
cultures. Spontaneous intracellular Ca2+ waves are indirect
measures of activity in astrocytes and synaptic firing in neurons,
and so Ca2+ imaging was conducted after 6 days of co-
culture. Neuronal events, observed in the small round cell
bodies (Supplementary Figure 3A), were of short duration but
involved a large change in fluorescent intensity from baseline
levels (Figure 4A). Astrocytic transients, observed in the large
cell bodies (Supplementary Figure 3B), were of significantly
longer duration and had a smaller change in emission intensity
(Figure 4B). To confirm the identity of these spontaneous events,
TTX was used at the end of recordings to block the Nav-
dependent neuronal action potentials (data not shown).
Co-culture with control or HD astrocytes led to a striking
increase in the percent of neurons with spontaneous events
compared to neurons cultured alone (p < 0.01; Figure 4C).
In addition, the frequency of events increased when neurons
were co-cultured with control and HD astrocytes (p < 0.001;
Figure 4D). Of note, however, the co-cultured HD astrocytes
were significantly less supportive of spontaneous events and the
frequency of events in control neurons (p < 0.05; Figures 4C,D)
compared to control astrocytes. This suggests that while both
astrocytes are supportive of neurons, the HD astrocytes are less
supportive of control neurons compared to control astrocytes.
When we examined Ca2+ waves in the iPSC-derived
astrocytes, we saw an increase in the proportion of astrocytes
exhibiting spontaneous transients when co-cultured with
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FIGURE 4 | Co-cultures of HD (HD109) and control (CTR33) astrocytes and neurons demonstrate alteration in neuronal firing at early time points and increased
toxicity in response to glutamate. (A) Example traces of calcium events in control neurons with control astrocytes. (B) Example traces of calcium events in control
astrocytes with control neurons. (C) Percentage of neurons with calcium events is higher in co-culture, but lower in HD astrocyte co-culture compared to control
astrocyte co-culture. (D) Frequency of events is higher in neurons in co-culture compared to mono-culture, but less frequent in HD astrocyte co-culture compared to
control astrocyte co-culture. (E) Percentage of astrocytes with calcium transients is greater in co-culture compared to mono-culture. (F) Astrocytes in mono-culture
had longer transients than in co-culture, and HD astrocytes in mono-culture had longer transients than control astrocytes. Co-culture of control or HD neurons with
HD astrocytes showed a longer duration of calcium transients compared to co-culture with control astrocytes. (G) Representative images of astrocyte and neuron
co-cultures around the 16 electrodes (black circles) of a 48-well MEA plate. (H) Example electrode traces showing spikes detected from control (CTR) or HD neurons
that are co-cultured with CTR or HD astrocytes. Scale bar: 12.5 µV vertical by 5 s horizontal. (I) Spontaneous activity from control and HD co-cultures. Significance
between conditions denoted as “a”: from NeuHD, “b”: from NeuCTR + AstCTR, “c”: from AstCTR + NeuHD. (J) No difference in total mean spike number per neuron in
co-culture conditions during daily 5 min recordings over the course of 16 days. Data is presented as separated by the neuron co-culture (gray lines, control neurons;
black lines, HD neurons), with solid lines representing control astrocytes and dashed lines indicating HD astrocytes. (K) Mean absorbance values of LDH activity in
media after 12 h incubation with 100 µM glutamate at 4 time points over 16 days. Significance between conditions denoted as “a”: from AstCTR, “b”: from AstCTR +
NeurCTR, “c”: from AstCTR + NeuHD. Ast, astrocyte; Neu, neuron; CTR, control. Calcium imaging: cells were analyzed from more than three separate experiments
using a Chi squared test. MEA: activity was analyzed using Kruskal–Wallis ANOVA on ranks with Dunn’s method from three experiments with 8–66 neurons per
condition at each time point. LDH, Analysis on data from triplicates measured at each of four time points across three experiments using one-way ANOVA with
Bonferroni correction for multiple comparison (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.005, and ∗∗∗∗p < 0.0001).
neurons (p < 0.05; Figure 4E). Although no difference was
observed in the amount of transient activity in monoculture, the
duration of transients in HD astrocytes was longer compared
to control astrocytes (p < 0.05; Figure 4F). Further, co-culture
with neurons decreased the duration of transients in both HD
and control astrocytes (p< 0.001; Figure 4F), which suggests the
neuron co-culture enhances the speed of intracellular calcium
signaling within astrocytes. However, in co-culture with either
control or HD neurons, the HD astrocytes generated longer
events compared to those in control astrocyte co-cultures
(p < 0.05; Figure 4F). This is a novel phenotype observed in
HD astrocytes, which could be the result of impaired Ca2+
modulation in HD iPSC-derived astrocytes, similar to what has
been reported in HD neurons (Lim et al., 2008).
To expand upon the Ca2+ imaging results and evaluate the
effects of co-culture over time, we employed microelectrode
array (MEA) analysis of Stage 4 HD and control astrocytes co-
cultured with HD and control neurons (Figure 4G). MEA allows
for non-invasive recordings of extracellular action potentials
generated by neuronal activity (Spira and Hai, 2013), which we
quantified as the mean spike number per neuron over 5 min.
First, we compared mono-culture and co-culture of HD and
control astrocytes and neurons from days 9–13 (Figure 4H).
As seen via calcium imaging, no difference was observed in
the activity between HD and control neurons in mono-culture,
while co-culture with astrocytes caused an increase in activity.
In contrast with calcium imaging, we did not observe lower
activity levels in neurons co-cultured with HD astrocytes.
Instead, co-culture of HD astrocytes with either control or HD
neurons caused an increase in spiking activity compared to that
observed with control astrocytes (NeuroCTR: 48.49 ± 14.53,
NeuroHD: 47.47 ± 24.50, NeuroCTR+AstCTR: 63.12 ± 14.64,
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NeuroHD+AstCTR: 68.89 ± 15.21, NeuroCTR+AstHD:
96.43 ± 21.80, NeuroHD+AstHD: 84.45 ± 17.37 spikes/5 min,
n = 15 to 207 neurons per condition, three separate experiments;
p < 0.001, p < 0.005, and p < 0.0001; Figure 4H). The contrast
between calcium imaging data and MEA activity is likely due
to the later time points of analysis in MEA (an additional
5 days in co-culture), which could allow for neurons to mature
further. However, when the activity was observed over the entire
25-day duration, no differences between the HD and control
astrocyte co-cultures could be seen (n = 8 to 166 neurons per
time point, three separate experiments; p = 0.293; Figure 4I).
This demonstrates that the initial decreased activity in control
neurons that are co-cultured with HD astrocytes observed with
calcium imaging, and then increase in activity of both control
and HD neurons that are co-cultured with HD astrocytes, are
transient phenotypes that attenuate over time in co-culture, as
evident by the longer duration MEA recordings.
HD Astrocytes Cannot Protect Against
Glutamate-Mediated Neuronal Toxicity
Decreased glutamate re-uptake is a component of the dysfunction
with striatal HD astrocytes (Bradford et al., 2009; Faideau et al.,
2010; Khakh et al., 2017). As such, we next assessed glutamate-
induced toxicity in astrocytes and co-cultures by measuring
lactate dehydrogenase (LDH) activity in the culture medium
after a 12-h incubation with excess (150 µM) glutamate
(Figure 4K). When cultured alone, the HD astrocytes had higher
levels of LDH activity compared to control astrocytes (AstCTR:
0.037 ± 0.001, AstHD: 0.070 ± 0.004 absorbance, n = 4 assays
per each of three experiments; p < 0.001). Indeed, co-culture of
control astrocytes with either HD or control neurons did not
increase the levels of LDH activity over that of control astrocytes
alone. This suggests that with control astrocyte co-culture,
neurons of either genotype do not cause an increase in toxicity
in response to glutamate. However, in the presence of HD
astrocytes, toxicity levels were increased with co-culture of both
control and HD neurons compared to control astrocyte co-
cultures, respectively (NeuroCTR+AstCTR: 0.047 ± 0.004,
NeuroHD+AstCTR: 0.060 ± 0.006, NeuroCTR+AstHD:
0.094 ± 0.007, NeuroHD+AstHD: 0.092 ± 0.007 absorbance;
p < 0.005 vs. control neuron; p < 0.001 vs HD neuron;
Figure 4K). Collectively, this data indicates that the HD
astrocytes are less proficient in preventing glutamate-induced
toxicity in neuron co-cultures compared to control astrocytes,
regardless of the disease state of the neurons.
GABA Expression Is Reduced in Neurons
Co-cultured With HD Astrocytes
Compared to Control Astrocytes
An interesting observation of cells in mono-culture
was that astrocytes had significantly larger nuclei
(p < 0.0001; Figure 5A) compared to the smaller
nuclei (Figure 5B) in iPSC-derived neurons, which was
consistent in co-cultures (p < 0.0001; Supplementary
Figure 4). This characteristic was used to subsequently
discriminate between astrocytes and neurons. Additionally,
both HD astrocytes (CTR Ast: 361.7 ± 24.93, HD
Ast: 516.2 ± 29.89 µm2, n = 50 each; p < 0.0001;
Figure 5) and neurons (CTR Neuro: 68.18 ± 2.22, HD
Neuro: 88.44 ± 2.82 µm2, n = 50 each; p < 0.0001;
Figure 5B) had significantly larger nuclei compared to the
respective control cells.
The neurotransmitter GABA is traditionally a marker of
inhibitory neurons (Molgaard et al., 2014), but it is also
expressed in glia (Lee et al., 2011), and levels of expression
are brain-region dependent (Yoon et al., 2011). Therefore, we
first assessed whether GABA expression differed in HD and
control lines. Immunocytochemistry showed that the cellular
localization of GABA was completely different in neurons
(small nuclei; Figures 5C,E) and astrocytes (large nuclei;
Figures 5D,E). IPSC-derived neurons had classical cytoplasmic
GABA expression in the form of dim puntca throughout
the cytoplasm, whereas astrocytes mainly expressed GABA
in bright perinuclear foci (Jo et al., 2014). We found that
more HD astrocytes expressed GABA-positive perinuclear foci
than control astrocytes, and this pattern was independent of
culture state (AstCTR: 11.86 ± 3.50, AstHD: 29.72 ± 4.66,
AstCTR+NeuroCTR 10.56± 2.55, AstCTR+NeuroHD 12.23± 1.45,
AstHD+NeuroCTR 27.80 ± 2.69, AstHD+NeuroHD 25.59 ± 4.38
bright GABA+ cells of total, n = 50 cells each, three
experiments; Figure 5F). Interestingly, while there was no
difference in the percentage of HD or control GABA-positive
neurons in mono-culture, the percentage of GABA-positive
control neurons increased when co-cultured with control
astrocytes (NeuroCTR: 44.63 ± 2.03, NeuroHD: 33.44 ± 1.53,
AstCTR+NeuroCTR 67.98± 0.38, AstCTR+NeuroHD 39.35± 5.25,
AstHD+NeuroCTR 38.94 ± 2.43, AstHD+NeuroHD 36.25 ± 1.42
dim GABA+ cells of total, n = 50 cells each, three experiments;
Figure 5G). This supports reports that astrocyte co-culture is
beneficial for neurogenesis and functional maturation (Johnson
et al., 2007). However, this astrocyte-facilitated augmentation
did not occur when HD astrocytes were cultured with
either control or HD neurons, indicating that HD astrocytes
are not as supportive of neuronal maturation as control
astrocytes. Additionally, control neurons co-cultured with
control astrocytes demonstrated increased GABA expression,
but this increase was not observed in HD neurons, suggesting
an inherent deficiency in HD neurons that cannot be rescued
by control glia.
DISCUSSION
Here, we present data from a novel protocol to generate
iPSC-derived astrocytes that are physiologically mature.
Using this protocol, HD astrocytes recapitulate phenotypes
previously seen in HD mouse models, such as impairment
of Kir currents, lengthened spontaneous Ca2+ waves, and
reduced cell membrane capacitance. They also demonstrated
that while the control astrocytes lead to increased neuronal
maturation, HD astrocytes were poorly supportive of
neuronal functional maturation. Overall, this study supports
and extends the idea that there are non-cell autonomous
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FIGURE 5 | Stage 4 HD (HD109) and control (CTR33) astrocytes (large nuclei, >210 µm2) and neurons (small nuclei, <141 µm2) in mono- or co-culture display
differences in both nuclear size and percent of cells expressing GABA. (A) HD astrocyte nuclei are larger than control astrocytes. No large nuclei are detected in the
neuronal cultures. (B) HD neuronal nuclei are larger than control neuronal nuclei. No small nuclei are detected in the Stage 4 astrocyte cultures. (C–E) GABA (red),
GFAP (white) and S100β (green) expression in panel (C) control and HD neurons, (D) control and HD astrocytes, (E) co-culture matrix of HD and control
astrocytes/neurons. (F) HD astrocytes in mono-culture or co-culture have a higher percentage of cells expressing a dim, punctate GABA compared to control
astrocytes. Significance between conditions denoted as “a”: from AstHD, “b”: from NeuCTR + AstHD, “c”: from AstHD + NeuHD. (G) Control neurons in mono-culture
have a higher percentage of cells expressing a bright cytoplasmic GABA stain than HD neurons in mono-culture, which is increased upon addition of control
astrocyte co-culture. Significance between conditions denoted as “a”: from AstCTR, “b”: from AstHD, “c”: from AstCTR + NeuCTR. These cells were analyzed from
more than three separate experiments. Ast, astrocyte; Neu, neuron; CTR, control. One-way ANOVA (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001).
contributions of astrocytes to the HD phenotype and shows that
iPSC-derived astrocytes and neurons in co-culture can be used
to effectively model HD.
Electrophysiological Assessment of
iPSC-Derived Astrocytes in vitro
Maturation of our astrocyte cultures was examined via
electrophysiological assessment. As expected, the intrinsic
membrane properties differed between immature (Type A and
B) and mature (Type C and D) astrocytes, which validated a
specification of maturation states (Higashi et al., 2001; Kofuji
and Newman, 2004). As evident in primary rodent astrocytes,
specific differences in intrinsic properties are observed in
electrophysiologicaly distinct astrocyte populations of which
the proportion of populations present changes as the animal
ages (Kimelberg et al., 2000; Zhou et al., 2006). For example,
astrocytes of the newborn rat hippocampus exhibit high
membrane resistance and depolarized membrane potentials,
which decrease and hyperpolarize with age, respectively.
We observed a similar trend in properties measured in our
iPSC-derived astrocyte Types. The astrocyte Types of our
cultures were further validated by expression of specific
K+ currents that are expressed by astrocytes in vivo across
development. In the rat hippocampus, the most prevalent
population of astrocytes in young animals (P1–P15) exhibit
outward-rectifying, voltage-gated potassium currents, whereas
the more mature astrocyte population observed in older animals
(P8–P106) presented more ohmic features of passive potassium
currents (Zhou et al., 2006). However, it is important to note
that our mature Type D astrocytes reach a maturation profile
comparable to intermediately mature astrocytes observed in
rodent preparations. This is not surprising, as human iPSC-
derived models have been shown to achieve maturation levels
similar to that observed in human fetal tissue yet fall short of
adult tissues based upon transcriptomic analysis (Ho et al.,
2016). Still, the trend identified in our astrocyte Types that show
maturation of intrinsic properties and expression of specific
potassium currents indicate that regardless of disease state, Type
C/D astrocytes were the most mature astrocytes with generally
larger and more complex physiology.
Glial Dysfunction in HD
Reactive astro-gliosis can be identified as an early feature
of HD, due to the increased GFAP immunoreactivity in
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prodromal gene-positive patients that continues to increase with
disease progression (Faideau et al., 2010). HD patient iPSC-
derived astrocytes display autophagocytic vacuoles (Juopperi
et al., 2012) and increased evoked inflammatory responses
(Hsiao et al., 2014). In our study, the iPSC-derived HD astrocytes
were found to have larger cell capacitances than control
astrocytes, indicative of an increased cell size. This increase
in astrocyte cell size is linked to reactive astrocytosis (Amenta
et al., 1998). Additionally, larger nuclei have been previously
observed in HD astrocytes, which has been attributed to a
reactive astrocyte pathotype (Aschner and Kimelberg, 1996). This
mirrors the larger HD astrocyte nuclei that was also observed
in our study. Additionally, increased GABA expression observed
in HD astrocytes has been linked to reactive astrocytosis (Jo
et al., 2014), and, depolarized HD astrocytes have a reduced
ability to release GABA via GAT3 (Wójtowicz et al., 2013).
This could explain the accumulation of GABA seen in HD
astrocytes in our study. Another explanation could be a
reduced capability for HD astrocytes to properly catabolize
GABA. It has been previously demonstrated that in HD
animal astrocytes GABA-glutamine cycling is compromised
(Skotte et al., 2018), and this could lead to an astrocytic
accumulation of GABA. Together, these observations truly
suggest that in vitro generation of HD iPSC-derived mature
astrocytes generates a reactive astrocyte population similarly to
that observed in vivo.
Astrocytes in HD mouse models have alterations in
mechanisms involved in extracellular ionic homeostasis,
including a decrease in expression of astrocyte-enriched
Kir4.1 channels (Tong et al., 2014). This reduction in Kir
current contributes to dysfunctional astrocyte glutamate and
Ca2+ signaling at a stage in mouse models which is similar
to the prodromal stage in patients (Jiang et al., 2016). This
dyshomeostasis of astrocytes contributes to the neuronal
loss seen in disease, due to elevated extracellular K+ and the
concomitant augmentation of neuronal excitability linked
to neuronal toxicity in HD (Tong et al., 2014). In fact,
overexpression of Kir4.1 channels in HD mouse astrocytes
in vivo normalizes extracellular K+, reverses aspects of neuronal
dysfunction, increases survival and attenuates some motor
phenotypes. In the present study, the HD iPSC-derived Type
C astrocytes displayed reduced peak Kir current densities
compared to control astrocytes, similar to the reduction
seen in vivo (Tong et al., 2014). This Kir current density
reduction was not mirrored in either the Type A/B Kv
or Type D K2P current densities. It has been previously
demonstrated that immature glial cells lack expression of Kir
channels (Sontheimer, 1994; Bordey and Sontheimer, 1997;
MacFarlane and Sontheimer, 2000), which would explain
the lack of phenotype in the Type A/B population. Upon
astrocyte maturation, an increase in Kir channel expression
causes a hyperpolarization of RMP from -50 to -80 mV
(Ransom and Sontheimer, 1995; Bordey and Sontheimer,
1997). This hyperpolarization is mirrored in the Type A/B
transition to Type C/D astrocytes. Not surprisingly then,
the depolarized resting membrane potential in Type C HD
astrocytes coincides with the reduced Kir current density.
Similarly, the absence of a significant difference between
HD and control astrocytes in K+ current density was
consistent with a lack of difference in RMP in the Type D
astrocytes, which display passive K2P currents rather than the
Kir currents.
Non-cell Autonomous Effects Seen in HD
Using Glial-Neuronal Co-culture
Paradigms
Non-cell autonomous effects of astrocytes in HD have been
demonstrated. Control murine neurons co-cultured with
HD glia are more susceptible to glutamate excitotoxicity
(Shin et al., 2005). Conversely, control murine glia provide
protection from excitotoxicity as seen in primary HD mouse
neurons (Shin et al., 2005). The data presented here with
human iPSC-derived astrocyte-neuron co-culture recapitulate
those findings. When we co-cultured control iPSC-derived
neurons with control iPSC-derived astrocytes, the neurons
had an increased proportion of GABA-expressing cells
and an increase in spontaneous activity at early stages
of co-culture. These are indicative that control astrocytes
support increased neuronal maturation more efficiently than
neuronal mono-culture. This is not surprising, as the benefit
of astrocyte co-culture for neuronal maturation and support
is well established (Johnson et al., 2007). However, when
control neurons were plated onto HD astrocytes for 6 days,
there was no increase in neuronal GABA expression, and
while there was increased spontaneous activity as compared
to in mono-culture, it was markedly less than co-culture
with control astrocytes. In agreement with the delayed
development phenotype previously proposed for HD iPSC-
derived models (Mattis et al., 2015; Ring et al., 2015; HD
iPSC Consortium, 2017), the HD and control neurons
co-cultured with HD astrocytes did achieve similar firing
rates after extended time in co-culture. Additionally, co-
cultures of either control or HD neurons with HD astrocytes
demonstrated increased toxicity after chronic glutamate
exposure, as compared to neurons on control astrocytes. These
observations demonstrate that the HD astrocytes do not support
neuronal maturation or function as effectively as control
astrocytes. This agrees with previous data demonstrating that
HD murine glia have a reduced ability to support neurons
due to a reduced ability to remove extracellular glutamate,
which contributes to the neuronal excitotoxic pathotype in HD
(Shin et al., 2005).
In this study, we generated physiologically mature iPSC-
derived astrocytes from HD patients and control subjects.
More excitingly, these astrocytes recapitulated an important
astrocyte HD pathology previously measured in mouse
models, the impairment of Kir currents, which had not yet
been measured in humans. Furthermore, we employed this
novel, iPSC-based human cell model to identify additional
astrocyte HD-pathotypes, including lengthened spontaneous
Ca2+ waves and reduced cell membrane capacitance. In the
future, this human HD patient iPSC-based neuronal-glial
co-culture system can be used to recapitulate key aspects of
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the disease for further elucidation of mechanistic pathways and
therapeutic intervention.
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